Rhumbline Advisers Syros Pharmaceuticals, Inc. Transaction History

Rhumbline Advisers

  • $105 Billion
  • Q2 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$0.69 - $1.21 $44,066 - $77,276
-63,865 Closed
0 $0
Q1 2022

May 12, 2022
SELL
$1.02 - $3.8 $2,848 - $10,613
-2,793 Reduced 4.19%
63,865 $76,000
Q4 2021

Feb 10, 2022
SELL
$3.26 - $4.66 $368 - $526
-113 Reduced 0.17%
66,658 $217,000
Q3 2021

Nov 12, 2021
BUY
$4.08 - $5.66 $8,388 - $11,636
2,056 Added 3.18%
66,771 $298,000
Q2 2021

Aug 05, 2021
BUY
$5.01 - $7.48 $90,265 - $134,767
18,017 Added 38.58%
64,715 $353,000
Q1 2021

May 06, 2021
SELL
$7.19 - $14.95 $5,644 - $11,735
-785 Reduced 1.65%
46,698 $349,000
Q4 2020

Feb 10, 2021
BUY
$6.66 - $14.66 $17,249 - $37,969
2,590 Added 5.77%
47,483 $515,000
Q3 2020

Nov 12, 2020
SELL
$8.69 - $14.47 $35,012 - $58,299
-4,029 Reduced 8.24%
44,893 $397,000
Q2 2020

Aug 13, 2020
BUY
$5.21 - $11.03 $49,354 - $104,487
9,473 Added 24.01%
48,922 $522,000
Q1 2020

May 06, 2020
BUY
$4.46 - $9.2 $280 - $579
63 Added 0.16%
39,449 $234,000
Q4 2019

Feb 05, 2020
BUY
$4.52 - $10.1 $2,074 - $4,635
459 Added 1.18%
39,386 $272,000
Q3 2019

Oct 23, 2019
SELL
$7.14 - $11.65 $1,927 - $3,145
-270 Reduced 0.69%
38,927 $404,000
Q2 2019

Aug 14, 2019
BUY
$5.5 - $9.75 $42,878 - $76,011
7,796 Added 24.83%
39,197 $363,000
Q1 2019

May 01, 2019
SELL
$5.51 - $9.59 $5,537 - $9,637
-1,005 Reduced 3.1%
31,401 $287,000
Q4 2018

Jan 31, 2019
BUY
$5.55 - $11.34 $61,022 - $124,683
10,995 Added 51.35%
32,406 $181,000
Q3 2018

Nov 07, 2018
SELL
$9.74 - $12.92 $10,334 - $13,708
-1,061 Reduced 4.72%
21,411 $255,000
Q2 2018

Aug 06, 2018
BUY
$10.16 - $13.65 $106,619 - $143,243
10,494 Added 87.61%
22,472 $229,000
Q1 2018

May 02, 2018
BUY
$9.47 - $12.98 $16,241 - $22,260
1,715 Added 16.71%
11,978 $155,000
Q4 2017

Feb 09, 2018
SELL
$8.45 - $17.48 $20,879 - $43,193
-2,471 Reduced 19.4%
10,263 $100,000
Q3 2017

Nov 06, 2017
BUY
$13.52 - $23.75 $172,163 - $302,432
12,734
12,734 $187,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $40.5M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email